Roche
Leads the Particle Design team within Roche’s Synthetic Molecules Pharmaceutical & Solid State Development organization, overseeing development of processes for small-molecule drug substances with an emphasis on final solid forms and solid-state attributes. This senior leadership role focuses on late-stage process development, interdisciplinary collaboration, and implementing strategies to ensure robust, phase-appropriate manufacturing and drug product quality.
Headquarters
Basel, Basel-Stadt, Switzerland
Company Size
10001+ employees
Founded
1896
As a pioneer in healthcare, we have been committed to improving lives since the company was founded in 1896 in Basel, Switzerland. Today, Roche creates innovative medicines and diagnostic tests that help millions of patients globally.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Roche.
Roche didn’t post a salary, so this is our estimate from similar listings.
Roche Breast-Cancer Drug Combination Misses Target in Study
3 days ago
Lilly pledges $500M to South Korea biopharma industry, following Roche’s lead
1 day ago
Solid-State Scientist
Eli Lilly and Company
Materials Science Lead
Pfizer
Crystallization & Particle Science Expert
FMC
Director, Small Molecule Drug Substance Development
Cogent Biosciences
Analytical Development Synthetic Molecules Characterization Scientist
BioLife Plasma Services
Scientist Linker Payload Manufacturing
BioNTech